pertuzumab,trastuzumab
roche
[]
#cedarssinaicancer at #gi23. dr. vi chiu is co-author on the poster #pertuzumab plus #trastuzumab in patients with biliary tract #cancer with erbb2/3 amplification, overexpression, or mutation presented at 12pm pt today. #gicsm 
Cedars-Sinai Cancer, ranked #9 in the nation in 2021 by U.S. News & World Report.